Mark Irving, PA
Medical · Lancaster, OHNPI 1902227184
Payments from drug & device makers
Across 84 payments — averaging $15.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$241
- Bayer$134
- Otsuka America Pharmaceutical, Inc.$118
- Xeris Pharmaceuticals, Inc.$107
- Novartis$90
- Exact Sciences$77
- plus $548 from 18 others
What the payments were for
- Food & beverage$1,315100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 14 | $241 |
| Bayer | 9 | $134 |
| Otsuka America Pharmaceutical, Inc. | 8 | $118 |
| Xeris Pharmaceuticals, Inc. | 6 | $107 |
| Novartis | 6 | $90 |
| Exact Sciences | 5 | $77 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 5 | $75 |
| Lilly USA, LLC | 5 | $71 |
| Grifols USA, LLC | 5 | $69 |
| Johnson & Johnson | 3 | $50 |
| Novo Nordisk | 3 | $38 |
| GSK | 2 | $33 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 1 | $33 |
| Amarin Pharma, Inc. | 2 | $27 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $19 |
| Corcept Therapeutics | 1 | $18 |
| Dexcom, Inc. | 1 | $18 |
| Pfizer | 1 | $17 |
| Medtronic | 1 | $14 |
| AstraZeneca | 1 | $14 |
| Sanofi-aventis U.S. LLC | 1 | $14 |
| Alkermes, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
| Avanir Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$1,315 in reported general payments places this provider in the 70th percentile of 547 medical providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Albuterol Sulfate HfaAlbuterol Sulfate | 20 | $489 |
| Clindamycin Hcl | 22 | $223 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 17 | $141 |
| Rosuvastatin Calcium | 11 | $137 |
| Azithromycin | 17 | $105 |
| Doxycycline Hyclate | 15 | $100 |
| Mupirocin | 13 | $98 |
| Cephalexin | 12 | $92 |
| Tizanidine Hcl | 17 | $77 |
| Losartan Potassium | 12 | $48 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other medical in Lancaster
- Shannon GhizzoniColumbus$116K
- Susan WhittCanal Winchester$74K
- Christopher FrickLima$46K
- Kodi VealeAkron$43K
- Abbey BlairCleveland$24K
- Joana ZulaConcord Twp$23K
- Chelsea AustenColumbus$21K
- Kristen FairchildToledo$19K
- Kaitlin SchuppGahanna$17K
- Melanie HunglerCincinnati$16K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.